Condition: HIV · Sponsor: International AIDS Vaccine Initiative
A Phase 1 Randomized Double Blinded Placebo Controlled, Dose Ranging Trial, of a Gorilla Adenovirus Vectored Networked Epitopes Vaccine (GRAdHIVNE1 Vaccine), Administered to Healthy Adults Living without HIV and Living with HIV, in Southern Africa
This description comes directly from the study's public registry record.
Vincent Muturi-Kioi, MBChB · +254-71-904-3151 · VMuturi-Kioi@iavi.org
Lebohang Molife, MBChB · +27 76 866 7282 · LMolife@iavi.org
Always discuss trial participation with your own doctor first.
| AHRI | Mtubatuba, KwaZulu-Natal, South Africa | Recruiting |
| DTHF | Cape Town, Western Cape, South Africa | Recruiting |
| Mutala | Harare, Harare, Zimbabwe | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06617091